Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction

Clinical Nephrology

Volumn 77, Issue 5, 2012, Pages 366-375

  Ganda, Anjali ^a   Weiner, Shepard D ^a   Chudasama, Neelesh L ^b   Valeri, Anthony M ^a   Jadoon, Atif ^a   Shimbo, Daichi ^a   Radhakrishnan, Jai ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

Echocardiography; Left ventricular hypertrophy; Renal dialysis

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; PHOSPHORUS; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY BIOPSY; LUNG EDEMA; M MODE ECHOCARDIOGRAPHY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PREDICTIVE VALUE; PULMONARY HYPERTENSION; PULSE PRESSURE; RETROSPECTIVE STUDY; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; CHRONIC DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK CITY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECOVERY OF FUNCTION; RENAL DIALYSIS; RETROSPECTIVE STUDIES; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84861491400     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107169     Document Type: Article

References (37)

1. Damman K, Navis G, Smilde TD, Voors AA, van der Bij W, van Veldhuisen DJ, Hillege HL. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007; 9: 872-878. doi:10.1016/j.ejheart.2007.05.010 PubMed
2. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009; 53: 582-588. doi:10.1016/j.jacc.20 08. 08.080 PubMed
3. Smilde TD, Damman K, van der Harst P, Navis G, Westenbrink BD, Voors AA, Boomsma F, van Veldhuisen DJ, Hillege HL. Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure. Clin Res Cardiol. 2009; 98: 121-129. doi:10.1007/ s00392-008-0732-z PubMed
4. Damman K, Voors AA, Hillege HL, Navis G, Lechat P, van Veldhuisen DJ, Dargie HJ; CIBIS-2 Investigators and Committees. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J Heart Fail. 2010; 12: 974-982. doi:10.1093/eurjhf/ hfq118 PubMed
5. Silberberg JS, Barre PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989; 36: 286-290. doi:10.1038/ki.1989.192 PubMed
6. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Serial change in echocardiographic parameters and cardiac failure in endstage renal disease. J Am Soc Nephrol. 2000; 11: 912-916. PubMed
7. Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol. 2010; 5: 805-813. doi:10.2215/CJN.07761109 PubMed
8. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995; 25: 879-884. doi:10.1016/0735-1097(94)00473-4 PubMed
9. Parfrey PS, Harnett JD, Griffiths SM, Gault MH, Barré PE. Congestive heart failure in dialysis patients. Arch Intern Med. 1988; 148: 1519-1525. doi:10.1001/archinte.148.7.1519 PubMed
10. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 1995: 884-890. doi:10.1038/ki.1995.132
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Chamber Quantification Writing GroupAmerican Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-1463. doi:10.1016/j. echo.2005.10.005 PubMed
12. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977; 55: 613-618. PubMed
13. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114: 345-352. PubMed
14. Bella JN, Wachtell K, Palmieri V, Liebson PR, Gerdts E, Ylitalo A, Koren MJ, Pedersen OL, Rokkedal J, Dahlöf B, Roman MJ, Devereux RB. Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study. J Hypertens. 2001; 19: 127-134. doi:10.1097/00004872-2001 01000-00017 PubMed
15. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992; 19: 1550-1558. doi:10.1016/0735-1097(92)90617-V PubMed
16. Gudmundsson P, Rydberg E, Winter R, Willenheimer R. Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods. Int J Cardiol. 2005; 101: 209-212. doi:10.1016/j.ijcard. 2004.03.027 PubMed
17. Estafanous F, Barash P. Reves J. Cardiac anesthesia: principles and clinical practice. 2nd ed., Philadelphia: Lippincott Williams & Wilkins; 2001. p. 258.
18. Ray SG, Metcalfe MJ, Oldroyd KG, Pye M, Martin W, Christie J, Dargie HJ, Cobbe SM. Do radionuclide and echocardiographic techniques give a universal cut off value for left ventricular ejection fraction that can be used to select patients for treatment with ACE inhibitors after myocardial infarction? Br Heart J. 1995; 73: 466-469. doi:10.1136/hrt.73.5.466 PubMed
19. Yuda S, Khoury V, Marwick TH. Influence of wall stress and left ventricular geometry on the accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 2002; 40: 1311-1319. doi:10.1016/S0735-1097(02)02105-8 PubMed
20. Robinson BM, Joffe MM, Pisoni RL, Port FK, Feldman HI. Revisiting survival differences by race and ethnicity among hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study. J Am Soc Nephrol. 2006; 17: 2910-2918. doi:10.1681/ASN.2005101078 PubMed
21. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995; 47: 186-192. doi:10.1038/ki.1995.22 PubMed
22. Wang AY, Chan JC, Wang M, Poon E, Lui SF, Li PK, Sanderson J. Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. Kidney Int. 2003; 63: 1899-1907. doi:10.1046/j.1523-1755.2003.00933.x PubMed
23. Wali RK, Wang GS, Gottlieb SS, Bellumkonda L, Hansalia R, Ramos E, Drachenberg C, Papadimitriou J, Brisco MA, Blahut S, Fink JC, Fisher ML, Bartlett ST, Weir MR. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol. 2005; 45: 1051-1060. doi:10.1016/j.jacc.2004.11.061 PubMed
24. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS. Left ventricular mass monitoring in the follow- up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int. 2004; 65: 1492-1498. doi:10.1111/j.1523-17 55 .2004.00530.x PubMed
25. Ozkahya M, Ok E, Cirit M, Aydin S, Akçiçek F, Başçi A, Dorhout Mees EJ. Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant. 1998; 13: 1489-1493. doi:10.1093/ndt/13.6.1489 PubMed
26. Vanholder R, Glorieux G, Lameire N; European Uremic Toxin Work Group. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant. 2003; 18: 463-466. doi:10.1093/ndt/18.3.463 PubMed
27. Mall G, Huther W, Schneider J, Lundin P, Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant. 1990; 5: 39-44. PubMed
28. Burt RK, Gupta-Burt S, Suki WN, Barcenas CG, Ferguson JJ, Van Buren CT. Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med. 1989; 111: 635-640. PubMed
29. Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD. Impact of renal transplantation on uremic cardiomyopathy. Transplantation. 1995; 60: 908-914. PubMed
30. Hutchinson TA, Thomas DC, MacGibbon B. Predicting survival in adults with end-stage renal disease: an age equivalence index. Ann Intern Med. 1982; 96: 417-423. PubMed
31. Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995; 47: 884-890. doi:10.1038/ki.1995.132 PubMed
32. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK et al. American College of Cardiology/American Heart Association. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001; 38: 2101-2113. doi:10.1016/S0735-1097(01)01683-7 PubMed
33. Hreybe H, Razak E, Saba S. Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol. 2007; 30: 1091-1095. doi:10.1111/j.1540-8159.2007.00818.x PubMed
34. Cice G, Ferrara L, Di Benedetto A, Russo PE, Marinelli G, Pavese F, Iacono A. Dilated cardiomyopathy in dialysis patients - beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol. 2001; 37: 407-411. doi:10.1016/S0735-1097(00)01158-X PubMed
35. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A et al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010; 31: 703-711. PubMed
36. Lemmilä S, Saha H, Virtanen V, Ala-Houhala I, Pasternack A. Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis. Am J Nephrol. 1998; 18: 404-410. doi:10.1159/000013384 PubMed
37. Hampl H, Hennig L, Rosenberger C, Amirkhalily M, Gogoll L, Riedel E, Scherhag A. Effects of optimized heart failure therapy and anemia correction with epoetin beta on left ventricular mass in hemodialysis patients. Am J Nephrol. 2005; 25: 211-220. doi:10.1159/000085881 PubMed